Central serous chorioretinopathy and antiphospholipid syndrome: Three cases report

Paul Billoir; Adrien Michon; Luc Darnige

doi:10.1177/0961203320979736

Central serous chorioretinopathy and antiphospholipid syndrome: Three cases report

Lupus. 2021 Mar;30(3):514-517. doi: 10.1177/0961203320979736. Epub 2020 Dec 13.

Authors

Paul Billoir¹, Adrien Michon², Luc Darnige^{3

4}

Affiliations

¹ Vascular Hemostasis Unit, Rouen University Hospital, Normandie Univ, UNIROUEN, INSERM U1096, Rouen, France.
² Service de médecine interne, hôpital européen Georges-Pompidou, Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, 20, Paris, France.
³ Service d'hématologie Biologique, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
⁴ INSERM UMR-S1140, Paris, France.

PMID: 33307985
DOI: 10.1177/0961203320979736

Abstract

Antiphospholipid syndrome (APS) is an acquired autoimmune disease characterized by recurrent venous or arterial thrombotic events and pregnancy morbidity, with persistently presence of antiphospholipid antibodies (aPL). We report three cases of central serous chorioretinopathy (CSC) associated with APS.

Keywords: Antiphospholipid syndrome; central serous chorioretinopathy; vision loss.

Publication types

Case Reports

MeSH terms

Adult
Antibodies, Antiphospholipid / immunology
Antiphospholipid Syndrome / complications*
Central Serous Chorioretinopathy / diagnosis
Central Serous Chorioretinopathy / etiology*
Female
Humans
Male
Middle Aged

Substances

Antibodies, Antiphospholipid